EPIRUS Biopharma (EPRS) Misses Q2 EPS by 27c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. FISV
10. CVS

Go back to EPIRUS Biopharma (EPRS) Misses Q2 EPS by 27c

EPIRUS Biopharmaceuticals Reports Second Quarter 2015 Financial Results

August 7, 2015 7:00 AM EDT

BOSTON, Aug. 07, 2015 (GLOBE NEWSWIRE) -- EPIRUS Biopharmaceuticals, Inc. (Nasdaq: EPRS), a Boston-based, pure-play biosimilar company focused on the global development and commercialization of biosimilar monoclonal antibodies, today announced financial results for the second quarter and six months ended June 30, 2015.

It has been key to our strategy to establish partnerships that align... More